TY - JOUR
KW - Drugs, Essential/administration & dosage
KW - England
KW - General Practitioners
KW - Guideline Adherence
KW - Humans
KW - Interprofessional Relations
KW - Interviews as Topic
KW - Mental Disorders/drug therapy
KW - Patient Care Team
AU - S. Crowe
AU - J. A. Cantrill
AU - M. P. Tully
A1 - 
AB - OBJECTIVE: To explore the challenges facing GPs' adherence to shared care arrangements for specialist drugs. DESIGN: A qualitative study using semistructured interviews; data analysed using the 'framework' approach aided by QSR N-Vivo 2.0. SETTING: Three Primary Care Trusts (PCTs) within one Strategic Health Authority (SHA) in the North West of England. PARTICIPANTS: 47 semistructured interviews were conducted with a range of Practice, PCT and SHA staff and other relevant stakeholders. RESULTS: GPs faced multiple challenges in adhering to shared care arrangements for specialist drugs. Psychiatric patients were given as an example where such arrangements were perceived as particularly difficult to maintain, with patient non-compliance a contributory factor. GP uncertainty and confusion surrounded the sharing of test results between primary and secondary care, and was felt to give rise to test duplication and omission. Of particular concern to GPs was the lack of compliance of practice and hospital colleagues with these arrangements, and the dependence they placed on specialists' responses to requests for advice. CONCLUSION: This study provides evidence of the numerous challenges facing GP adherence to shared care arrangements. Such challenges need to be overcome if the issues of test duplication and omission are to be addressed, and GPs' future acceptance of shared care arrangements encouraged.
BT - Quality & safety in health care
C5 - General Literature
CP - 6
CY - England
DO - 10.1136/qshc.2009.035857
IS - 6
JF - Quality & safety in health care
N2 - OBJECTIVE: To explore the challenges facing GPs' adherence to shared care arrangements for specialist drugs. DESIGN: A qualitative study using semistructured interviews; data analysed using the 'framework' approach aided by QSR N-Vivo 2.0. SETTING: Three Primary Care Trusts (PCTs) within one Strategic Health Authority (SHA) in the North West of England. PARTICIPANTS: 47 semistructured interviews were conducted with a range of Practice, PCT and SHA staff and other relevant stakeholders. RESULTS: GPs faced multiple challenges in adhering to shared care arrangements for specialist drugs. Psychiatric patients were given as an example where such arrangements were perceived as particularly difficult to maintain, with patient non-compliance a contributory factor. GP uncertainty and confusion surrounded the sharing of test results between primary and secondary care, and was felt to give rise to test duplication and omission. Of particular concern to GPs was the lack of compliance of practice and hospital colleagues with these arrangements, and the dependence they placed on specialists' responses to requests for advice. CONCLUSION: This study provides evidence of the numerous challenges facing GP adherence to shared care arrangements. Such challenges need to be overcome if the issues of test duplication and omission are to be addressed, and GPs' future acceptance of shared care arrangements encouraged.
PP - England
PY - 2010
SN - 1475-3901; 1475-3898
T1 - Shared care arrangements for specialist drugs in the UK: the challenges facing GP adherence
T2 - Quality & safety in health care
TI - Shared care arrangements for specialist drugs in the UK: the challenges facing GP adherence
U1 - General Literature
U2 - 20554577
U3 - 10.1136/qshc.2009.035857
VL - 19
VO - 1475-3901; 1475-3898
Y1 - 2010
ER -